Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: a literature …
C Mörth, A Valachis - Lung Cancer, 2014 - Elsevier
Background The purpose of this study was to compare the efficacy and tolerability of first-line
treatment with combination versus single agent chemotherapy in patients with advanced …
treatment with combination versus single agent chemotherapy in patients with advanced …
Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: A literature …
C Mörth, A Valachis - Lung Cancer, 2014 - diva-portal.org
BACKGROUND: The purpose of this study was to compare the efficacy and tolerability of first-
line treatment with combination versus single agent chemotherapy in patients with advanced …
line treatment with combination versus single agent chemotherapy in patients with advanced …
Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: A literature …
C Mörth, A Valachis - Lung Cancer, 2014 - infona.pl
The purpose of this study was to compare the efficacy and tolerability of first-line treatment
with combination versus single agent chemotherapy in patients with advanced non-small …
with combination versus single agent chemotherapy in patients with advanced non-small …
[引用][C] Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: A …
C MÖRTH, A VALACHIS - Lung cancer, 2014 - pascal-francis.inist.fr
Single-agent versus combination chemotherapy as first-line treatment for patients with
advanced non-small cell lung cancer and performance status 2: A literature-based meta-analysis …
advanced non-small cell lung cancer and performance status 2: A literature-based meta-analysis …
Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: a literature …
C Mörth, A Valachis - Lung Cancer (Amsterdam, Netherlands), 2014 - europepmc.org
Background The purpose of this study was to compare the efficacy and tolerability of first-line
treatment with combination versus single agent chemotherapy in patients with advanced …
treatment with combination versus single agent chemotherapy in patients with advanced …
Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: a literature …
C Mörth, A Valachis - Lung cancer (Amsterdam …, 2014 - pubmed.ncbi.nlm.nih.gov
Background The purpose of this study was to compare the efficacy and tolerability of first-line
treatment with combination versus single agent chemotherapy in patients with advanced …
treatment with combination versus single agent chemotherapy in patients with advanced …
Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: A literature …
C Mörth, A Valachis - Lung Cancer, 2014 - lungcancerjournal.info
Background The purpose of this study was to compare the efficacy and tolerability of first-line
treatment with combination versus single agent chemotherapy in patients with advanced …
treatment with combination versus single agent chemotherapy in patients with advanced …
Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: A literature …
C Mörth, A Valachis - Lung Cancer, 2014 - infona.pl
The purpose of this study was to compare the efficacy and tolerability of first-line treatment
with combination versus single agent chemotherapy in patients with advanced non-small …
with combination versus single agent chemotherapy in patients with advanced non-small …